let-7g-5p suppresses the proliferation and expansion of hepatic stellate cells in liver fibrosis via targeting FGF5

Hepatic stellate cells (HSCs) and their activated phenotype (activated HSCs, aHSCs) function as crucial effector cells in the onset of liver fibrosis. In recent years, microRNAs (miRNAs) have emerged as a promising therapeutic approach for diseases. To explore early intervention strategies for HSCs...

Full description

Bibliographic Details
Main Authors: Zhou, Jiaming, Huang, Siyan, Yang, Yidan, Cong, Yutong, Chen, Yuwen, Ding, Youyou, Lu, Mengwen, Li, Meiyuan
Format: Article
Language:English
Published: Penerbit Universiti Kebangsaan Malaysia 2025
Online Access:http://journalarticle.ukm.my/25215/
http://journalarticle.ukm.my/25215/1/SMD%2020.pdf
_version_ 1848816299574034432
author Zhou, Jiaming
Huang, Siyan
Yang, Yidan
Cong, Yutong
Chen, Yuwen
Ding, Youyou
Lu, Mengwen
Li, Meiyuan
author_facet Zhou, Jiaming
Huang, Siyan
Yang, Yidan
Cong, Yutong
Chen, Yuwen
Ding, Youyou
Lu, Mengwen
Li, Meiyuan
author_sort Zhou, Jiaming
building UKM Institutional Repository
collection Online Access
description Hepatic stellate cells (HSCs) and their activated phenotype (activated HSCs, aHSCs) function as crucial effector cells in the onset of liver fibrosis. In recent years, microRNAs (miRNAs) have emerged as a promising therapeutic approach for diseases. To explore early intervention strategies for HSCs activation and proliferation, miRNA profiles were sequenced from three patients with chronic hepatitis B-related hepatic fibrosis (HF). The miRNAs sequencing experiment and data analysis were conducted utilizing the Illumina HiSeq 4000 platform. In vitro, the proliferation and expansion capabilities of HSCs were detected using CCK8, EdU and colony formation assays. The examination of α-SMA, the indicator aHSCs, was performed through western blot assays. For in vivo investigation of the let-7g-5p/FGF5 axis, a bile duct ligation (BDL)-induced HF mice model was constructed and mmu-let-7g-5p agomir was delivered to mice via tail vein injection. Collagen deposition and the α-SMA level were assessed through histological staining including H&E, Masson, Van Gieson(VG), and immunohistochemical (IHC) staining. The miRNAs sequencing and bioinformatics analysis identified let-7g-5p as a promising anti-HF candidate. qRT-PCR and dual-luciferase reporter assays confirmed FGF5 as the direct target of let-7g-5p. let-7g-5p hampered the proliferation and expansion abilities of HSCs and decreased the α-SMA level by targeting FGF5 in vitro. In addition, H&E, Masson, VG and IHC staining demonstrated the let-7g-5p/FGF5 axis significantly mitigated collagen deposition and decreased α-SMA production in the BDL-induced HF mice. let-7g-5p suppressed the proliferation and expansion of HSCs and alleviated HF via targeting FGF5. The let-7g-5p/FGF5 axis could be an effective therapeutic target for reducing aHSCs abundance in HF.
first_indexed 2025-11-15T01:03:40Z
format Article
id oai:generic.eprints.org:25215
institution Universiti Kebangasaan Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T01:03:40Z
publishDate 2025
publisher Penerbit Universiti Kebangsaan Malaysia
recordtype eprints
repository_type Digital Repository
spelling oai:generic.eprints.org:252152025-05-13T08:11:58Z http://journalarticle.ukm.my/25215/ let-7g-5p suppresses the proliferation and expansion of hepatic stellate cells in liver fibrosis via targeting FGF5 Zhou, Jiaming Huang, Siyan Yang, Yidan Cong, Yutong Chen, Yuwen Ding, Youyou Lu, Mengwen Li, Meiyuan Hepatic stellate cells (HSCs) and their activated phenotype (activated HSCs, aHSCs) function as crucial effector cells in the onset of liver fibrosis. In recent years, microRNAs (miRNAs) have emerged as a promising therapeutic approach for diseases. To explore early intervention strategies for HSCs activation and proliferation, miRNA profiles were sequenced from three patients with chronic hepatitis B-related hepatic fibrosis (HF). The miRNAs sequencing experiment and data analysis were conducted utilizing the Illumina HiSeq 4000 platform. In vitro, the proliferation and expansion capabilities of HSCs were detected using CCK8, EdU and colony formation assays. The examination of α-SMA, the indicator aHSCs, was performed through western blot assays. For in vivo investigation of the let-7g-5p/FGF5 axis, a bile duct ligation (BDL)-induced HF mice model was constructed and mmu-let-7g-5p agomir was delivered to mice via tail vein injection. Collagen deposition and the α-SMA level were assessed through histological staining including H&E, Masson, Van Gieson(VG), and immunohistochemical (IHC) staining. The miRNAs sequencing and bioinformatics analysis identified let-7g-5p as a promising anti-HF candidate. qRT-PCR and dual-luciferase reporter assays confirmed FGF5 as the direct target of let-7g-5p. let-7g-5p hampered the proliferation and expansion abilities of HSCs and decreased the α-SMA level by targeting FGF5 in vitro. In addition, H&E, Masson, VG and IHC staining demonstrated the let-7g-5p/FGF5 axis significantly mitigated collagen deposition and decreased α-SMA production in the BDL-induced HF mice. let-7g-5p suppressed the proliferation and expansion of HSCs and alleviated HF via targeting FGF5. The let-7g-5p/FGF5 axis could be an effective therapeutic target for reducing aHSCs abundance in HF. Penerbit Universiti Kebangsaan Malaysia 2025 Article PeerReviewed application/pdf en http://journalarticle.ukm.my/25215/1/SMD%2020.pdf Zhou, Jiaming and Huang, Siyan and Yang, Yidan and Cong, Yutong and Chen, Yuwen and Ding, Youyou and Lu, Mengwen and Li, Meiyuan (2025) let-7g-5p suppresses the proliferation and expansion of hepatic stellate cells in liver fibrosis via targeting FGF5. Sains Malaysiana, 54 (3). pp. 881-898. ISSN 0126-6039 https://www.ukm.my/jsm/english_journals/vol54num3_2025/contentsVol54num3_2025.html
spellingShingle Zhou, Jiaming
Huang, Siyan
Yang, Yidan
Cong, Yutong
Chen, Yuwen
Ding, Youyou
Lu, Mengwen
Li, Meiyuan
let-7g-5p suppresses the proliferation and expansion of hepatic stellate cells in liver fibrosis via targeting FGF5
title let-7g-5p suppresses the proliferation and expansion of hepatic stellate cells in liver fibrosis via targeting FGF5
title_full let-7g-5p suppresses the proliferation and expansion of hepatic stellate cells in liver fibrosis via targeting FGF5
title_fullStr let-7g-5p suppresses the proliferation and expansion of hepatic stellate cells in liver fibrosis via targeting FGF5
title_full_unstemmed let-7g-5p suppresses the proliferation and expansion of hepatic stellate cells in liver fibrosis via targeting FGF5
title_short let-7g-5p suppresses the proliferation and expansion of hepatic stellate cells in liver fibrosis via targeting FGF5
title_sort let-7g-5p suppresses the proliferation and expansion of hepatic stellate cells in liver fibrosis via targeting fgf5
url http://journalarticle.ukm.my/25215/
http://journalarticle.ukm.my/25215/
http://journalarticle.ukm.my/25215/1/SMD%2020.pdf